Berenson J - Search Results

1

Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.

Schiller G, Nimer S, Vescio R, Lieb G, Lee M, Gajewski J, Territo M, Berenson J. Schiller G, et al. Among authors: berenson j. Bone Marrow Transplant. 1994 Jul;14(1):131-6. Bone Marrow Transplant. 1994. PMID: 7951100 Clinical Trial.

2

Expression of shared idiotypes by paraproteins from patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Berenson JR, Lichtenstein A, Hart S, Palomares D, Miller RA. Berenson JR, et al. Blood. 1990 Jun 1;75(11):2107-11. Blood. 1990. PMID: 1693294 Free article.

3

Clonal rearrangement of the beta-T cell receptor gene in multiple myeloma.

Berenson J, Lichtenstein A. Berenson J, et al. Leukemia. 1989 Feb;3(2):133-6. Leukemia. 1989. PMID: 2536128

4

A CD10-positive subset of malignant cells is identified in multiple myeloma using PCR with patient-specific immunoglobulin gene primers.

Cao J, Vescio RA, Rettig MB, Hong CH, Kim A, Lee JC, Lichtenstein AK, Berenson JR. Cao J, et al. Among authors: berenson jr. Leukemia. 1995 Nov;9(11):1948-53. Leukemia. 1995. PMID: 7475288

5

Analysis of multiple myeloma third complementarity-determining regions reveals characteristics of prenatal B cells.

Kunkel LA, Vescio R, Cao J, Hong CH, Kim A, Schiller GJ, Lichtenstein AK, Berenson JR. Kunkel LA, et al. Among authors: berenson jr. Ann N Y Acad Sci. 1995 Sep 29;764:519-22. doi: 10.1111/j.1749-6632.1995.tb55876.x. Ann N Y Acad Sci. 1995. PMID: 7486579 No abstract available.

6

The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma.

Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR. Vescio RA, et al. Among authors: berenson rj, berenson jr. Blood. 1994 Nov 15;84(10):3283-90. Blood. 1994. PMID: 7524734 Free article. Clinical Trial.

7

Multiple myeloma clones are derived from a cell late in B lymphoid development.

Berenson JR, Vescio RA, Hong CH, Cao J, Kim A, Lee CC, Schiller G, Berenson RJ, Lichtenstein AK. Berenson JR, et al. Among authors: berenson rj. Curr Top Microbiol Immunol. 1995;194:25-33. doi: 10.1007/978-3-642-79275-5_4. Curr Top Microbiol Immunol. 1995. PMID: 7534671

8

Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity.

Vescio RA, Cao J, Hong CH, Lee JC, Wu CH, Der Danielian M, Wu V, Newman R, Lichtenstein AK, Berenson JR. Vescio RA, et al. Among authors: berenson jr. J Immunol. 1995 Sep 1;155(5):2487-97. J Immunol. 1995. PMID: 7650379

9

Interleukin-6 inhibits apoptosis of malignant plasma cells.

Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J. Lichtenstein A, et al. Among authors: berenson j. Cell Immunol. 1995 May;162(2):248-55. doi: 10.1006/cimm.1995.1076. Cell Immunol. 1995. PMID: 7743552

10

Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.

Cao J, Vescio RA, Hong CH, Kim A, Lichtenstein AK, Berenson JR. Cao J, et al. Among authors: berenson jr. J Clin Invest. 1995 Mar;95(3):964-72. doi: 10.1172/JCI117805. J Clin Invest. 1995. PMID: 7883997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters